Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Xenotransplantation. 2021 Nov;28(6):e12713. doi: 10.1111/xen.12713

Figure 4. RhATG effectively depletes T lymphocytes.

Figure 4.

(a) RhATG treated animals demonstrated reduction in total lymphocyte (p<0.01) and T cell absolute counts (p<0.01) when compared to basiliximab controls. B cell counts were similarly decreased in both study groups (p=ns). (b) RhATG treated recipients underwent inversion CD4:CD8 ratio following induction which remained throughout the study period (p<0.01).